Tarsus Pharmaceuticals, Inc. (TARS) — SC 13G Filings
All SC 13G filings from Tarsus Pharmaceuticals, Inc.. Browse 5 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (5)
- SC 13G Filing — Nov 14, 2024
- SC 13G Filing — Nov 12, 2024
-
Morgan Stanley Discloses Passive Stake in Tarsus Pharmaceuticals
— Feb 9, 2024 Risk: low
Morgan Stanley, a major financial institution, filed an SC 13G on February 9, 2024, disclosing its ownership of Tarsus Pharmaceuticals, Inc. common stock as of -
BlackRock Discloses Passive Stake in Tarsus Pharmaceuticals
— Jan 26, 2024
BlackRock, Inc. has filed an SC 13G indicating its ownership in Tarsus Pharmaceuticals, Inc. as of December 31, 2023. This filing, made under Rule 13d-1(b), sig -
Paradigm BioCapital Advisors Takes 1.9M Share Stake in Tarsus Pharma
— Jan 22, 2024
Paradigm BioCapital Advisors LP, a Delaware-based investment firm, reported beneficial ownership of 1,927,506 shares of Tarsus Pharmaceuticals, Inc. common stoc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX